Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 145

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 145
---
 or restrictions on the repatriation of the proceeds from this offering into the PRC, restrictions on
or prohibition of the payments or remittance of dividends by our PRC subsidiary, or other actions that could have a material and adverse
effect on our business, financial condition, results of operations, reputation and prospects, as well as the trading price of our Class
A ordinary shares. Furthermore, the CSRC or other PRC regulatory agencies may also take actions requiring us, or making it advisable for
us, to halt this offering before the settlement and delivery of the Class A ordinary shares that we are offering. Consequently, if you
engage in market trading or other activities in anticipation of and prior to the settlement and delivery of the Class A ordinary shares
we are offering, you would be doing so at the risk that the settlement and delivery may not occur.

<div align='center'>31

CAPITALIZATION AND INDEBTNESS</div>

Our capitalization will
be set forth in the applicable prospectus supplement or in a report on Form 6-K subsequently furnished to the SEC and specifically
incorporated by reference into this prospectus.

<div align='center'>DILUTION</div>

If required, we will
set forth in a prospectus supplement the following information regarding any material dilution of the equity interests of investors purchasing
securities in an offering under this prospectus:

| ● | the net tangible book value per share of our equity securities before and after the offering; |

| ● | the amount of the increase in such net tangible book value per share attributable to the cash payments made by purchasers in the offering; and |

| ● | the amount of the immediate dilution from the public offering price which will be absorbed by such purchasers. |

<div align='center'>32

USE OF PROCEEDS</div>

We intend to use the net proceeds from the sale of securities we offer as indicated in the applicable prospectus supplement, information incorporated by reference, or free writing prospectus.

<div align='center'>DESCRIPTION OF ORDINARY SHARES</div>

Lichen China Limited is an exempted company incorporatedunder the Companies Act (Revised) of the Cayman Islands, as amended (the “Cayman Islands
Companies Act”). Pursuant to our amended and restated memorandum and amended and restated articles of association, the authorized
share capital of our company is US$50,000, divided into 1,000,000,000 Class A ordinary shares of a par value of US$0